Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality


HERBORT C. P. , ABU EL ASRAR A. M. , Yamamoto J. H. , PAVESIO C. E. , GUPTA V., KHAIRALLAH M., ...More

INTERNATIONAL OPHTHALMOLOGY, vol.37, no.6, pp.1383-1395, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 37 Issue: 6
  • Publication Date: 2017
  • Doi Number: 10.1007/s10792-016-0395-0
  • Title of Journal : INTERNATIONAL OPHTHALMOLOGY
  • Page Numbers: pp.1383-1395

Abstract

Vogt-Koyanagi-Harada (VKH) disease is a primary autoimmune stromal choroiditis. Aim of the study was to gather a body of evidence from the literature and from experts that systemic corticosteroid combined with non-steroidal immunosuppressive therapy should become the standard of care in initial-onset VKH disease.